Talukdar Lavina
SEC insider (Form 3/4/5 filer). CIK 0002059193. Director at Monopar Therapeutics (MNPR). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in WILMETTE, IL.
Companies Talukdar Lavina has filed insider reports for
- Monopar Therapeutics (MNPR): Director
Talukdar Lavina
CIK: 0002059193
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MNPR
Monopar Therapeutics
Director